CASP3 and Alzheimer disease: In an AD-like rat brain model, Goswami and colleagues demonstrated that Aβ1-42 treatment resulted in a multifaceted response comprising increased cell death, accompanied by elevated caspase-3 and caspase-12 activity, ER stress activation, and ISR pathway suppression, as indicated by reduced levels of p-eIF2α [136].